The FDA has approved Avance® (acellular nerve allograft-arwx) for treating sensory nerve discontinuity. Derived from cadaveric nerve tissue, Avance bridges gaps in injured peripheral nerves ...
RESEARCHERS have replicated the body’s blood-producing system by creating a bone marrow model made entirely from reprogrammed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback